Oppenheimer & Co’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-12,535
| Closed | -$1.71M | – | 1423 |
|
|
2018
Q2 | $1.71M | Sell |
12,535
-700,305
| -98% | -$63.6M | 0.05% | 430 |
|
|
2018
Q1 | $56.1M | Sell |
712,840
-120
| -0% | -$8.86K | 1.44% | 4 |
|
|
2017
Q4 | $48.6M | Sell |
712,960
-10,520
| -1% | -$546K | 1.25% | 7 |
|
|
2017
Q3 | $29.1M | Buy |
723,480
+39,390
| +6% | +$1.52M | 0.78% | 14 |
|
|
2017
Q2 | $27.2M | Buy |
684,090
+9,050
| +1% | +$331K | 0.75% | 17 |
|
|
2017
Q1 | $21.8M | Sell |
675,040
-28,541
| -4% | -$712K | 0.62% | 23 |
|
|
2016
Q4 | $12.5M | Sell |
703,581
-17,690
| -2% | -$381K | 0.36% | 66 |
|
|
2016
Q3 | $16.8M | Buy |
721,271
+47,350
| +7% | +$1.07M | 0.49% | 42 |
|
|
2016
Q2 | $12.6M | Buy |
673,921
+251,370
| +59% | +$4.54M | 0.37% | 66 |
|
|
2016
Q1 | $7.68M | Buy |
422,551
+24,710
| +6% | +$398K | 0.23% | 96 |
|
|
2015
Q4 | $8.38M | Buy |
397,841
+15,500
| +4% | +$299K | 0.25% | 94 |
|
|
2015
Q3 | $7.05M | Buy |
382,341
+198,982
| +109% | +$4.97M | 0.21% | 108 |
|
|
2015
Q2 | $6.21M | Buy |
183,359
+91,439
| +99% | +$3.68M | 0.17% | 134 |
|
|
2015
Q1 | $4.42M | Sell |
91,920
-2,399
| -3% | -$109K | 0.12% | 197 |
|
|
2014
Q4 | $2.1M | Buy |
94,319
+69,360
| +278% | +$1.6M | 0.06% | 373 |
|
|
2014
Q3 | $473K | Buy |
24,959
+13,889
| +125% | +$331K | 0.01% | 872 |
|
|
2014
Q2 | $299K | Buy |
+11,070
| New | +$281K | 0.01% | 1054 |
|
Oppenheimer & Co's FMI Position: Q3 2018 in Review
Oppenheimer & Co sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 12,535 shares — an estimated $1.71M sold.
Oppenheimer & Co first reported a position in FMI in Q2 2014 and held it in 17 quarters. The position peaked at $56.1M in Q1 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Oppenheimer & Co reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Oppenheimer & Co sold 12,535 Foundation Medicine, Inc. shares in Q3 2018, an estimated $1.71M.
- Oppenheimer & Co first reported a position in Foundation Medicine, Inc. in Q2 2014 and held it in 17 quarters.
- Oppenheimer & Co's Foundation Medicine, Inc. position peaked at $56.1M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Oppenheimer & Co's 13F filing for Q3 2018, filed 26 Oct 2018.